MLL5/KMT2E anticorps
Aperçu rapide pour MLL5/KMT2E anticorps (ABIN6775838)
Antigène
Voir toutes MLL5/KMT2E (MLL5) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Human KMT2E / MLL5.
-
Purification
- Affinity purified
-
Immunogène
-
Recombinant Protein of human KMT2E
Type of Immunogen: Recombinant protein -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: IF (1:50 - 1:200), IHC (1:50 - 1:200), IP (1:50 - 1:100), WB (1:500 - 1:2000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- MLL5/KMT2E (MLL5) (Myeloid/lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog) (MLL5))
-
Autre désignation
- KMT2E / MLL5
-
Sujet
-
Name/Gene ID: KMT2E
Synonyms: KMT2E, Lysine N-methyltransferase 2E, MLL5, HDCMC04P -
ID gène
- 55904
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, L'effet Warburg
Antigène
-